Good morning and welcome to Olin Corporation's third quarter 2026 earnings conference call. All participants will be in a listen only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. Following today's brief opening comments, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your touch tone phone. To withdraw your question, please press star, then two. Please note this event is being recorded. I would now like to turn the conference over to Steve Keenan, Olin's Director of Investor Relations. Please go ahead, Steve.

Thank you, operator. Good morning, everyone. We appreciate you joining us today to review Olin's third quarter 2026 results. Please keep in mind that today's discussion, together with the associated slides, as well as the question and answer session that follows, will include statements regarding estimates or expectations of future performance. Please note these are forward-looking statements and that actual results could differ materially from those projected. Some of the factors that could cause actual results to differ from our projections are described without limitations in the Risk Factors section of our most recent Form 10-K and in yesterday's third quarter earnings press release. A copy of today's transcript and slides will be available on our website in the Investors section under Past Events. Our earnings press release and related financial data and information are available under press releases. With me this morning are Ken Lane, Olin's President and CEO, and Todd Slater, Olin's CFO. We'll start with some prepared remarks, then we look forward to taking your questions. Let me now turn the call over to Olin's President and CEO, Ken Lane.

Thanks, Steve, and thank you to everyone joining us today. We appreciate your interest in Olin. Let's start on slide three with a high-level review of the third quarter. The quarter reflected much of what we discussed on our last call. Each business remained focused on serving customers, maintaining commercial discipline, reducing structural costs, and generating cash in what continues to be a very dynamic environment. During the quarter, our team made progress in several important areas. We completed our work at the Freeport site, Returning our VCM assets to normal operations in mid-September is planned. The caustic soda market remained resilient, and Olin's commercial team maximized our third quarter caustic value against a turbulent export market. Our epoxy business continues to benefit from our self-help actions, our formulated solutions growth, and our commitment to support local customers seeking secure and reliable supply in both the U.S. and Europe. Commercial ammunition demand at Winchester has improved year over year, and our military business continues to gain momentum with new contract awards, recognizing our strong performance as an essential supplier to the U.S. warfighter. Finally, we've stepped up our integration planning for the Olin-Huntsman merger as regulatory approvals accelerate. Our day-to-day focus remains unchanged as we prioritize safe, reliable, and consistent execution across the company. Turning to slide four, let me share an update on our planned merger with Huntsman. Our August shareholder meeting returned overwhelming support for this transaction, providing a clear mandate while also passing a threshold of support to preserve the low-interest Huntsman bonds. We continue to make good progress toward closing. We've cleared the Hart-Scott-Rodino waiting period here in the United States, and we've received regulatory approval in several other key jurisdictions. Reviews continue in the remaining regions, including Europe and China. And with the progress we have seen so far, we now expect to close in the first quarter of 2027. Our immediate priority is being ready to execute on day one. Under Todd's leadership, we've accelerated our pre-closing integration planning to align with the first quarter of 2027 closing. We remain confident in our ability to deliver more than $400 million of cost synergies and integration benefits and the planning we're doing now will help us make a fast start after closing. I think it's important to understand how we're approaching integration. We're building a new company with an industry leading, globally advantaged asset base and a highly talented team. We're designing our organization based on industry leading benchmarks, building a lean and efficient company focused on the essential operations that create value for our customers, shareholders and team members. Our organizational design will be data driven with clear lines of accountability and incentive programs that drive results. We'll be sharing more about Olin Huntsman in the coming weeks. In the meantime, we're announcing today that the ticker symbol for Olin Huntsman will be OHN following closing. Now let's turn to slide five for a closer look at our core alkali products and vinyls third quarter performance. As expected, we resumed normal operations at our Freeport BCM facility. Reduced operating rates resulted in approximately $30 million of negative impact. While we sold more EDC during the quarter, EDC values have moderated from second quarter, but remain above pre-conflict levels. Domestic caustic soda prices improved slightly on similar volumes to second quarter. Export pricing was significantly pressured by excess Chinese production. Flooring volume was lower due to customer maintenance activity, while water treatment was seasonally strong. With industry shutdowns, seasonally slower vinyls demand, and increasing global costs of energy, feedstocks, and freight, caustic markets are tightening as we come to the end of the year. We've announced price increases and expect to realize those in the first quarter of 2027. Turning to slide six, let's review our epoxy results. Olin's epoxy business continues to improve, supported by our self-help actions and margin management that is critical as we see significant increases in feedstock costs. Remaining focused on what we can control, we've materially improved the cost structure of the business, and we continue to leverage Olin's position as a reliable, vertically integrated local supplier to customers in both the US and Europe. We also continue to grow our higher value formulated solutions portfolio, particularly in applications across electronics, composites, and coatings. Lower price volatility has caused dramatic swings in benzene and propylene prices. Our epoxy team has acted quickly to offset that with announced price increases. Fuel surcharges have also been implemented across all regions and shipping modes to mitigate rising diesel and transportation costs. Europe is now considering safeguard protections to shield its composites value chain from subsidized Asian overcapacity. If successful, this initiative will benefit a broad group of composite input materials, including epoxy resins and related systems, which are all essential to critical industries including automotive, wind energy, aerospace, and defense. It is critical that the European Union act decisively to seize this momentum and swiftly establish provisional measures. Olin has provided support throughout this process and will continue to do so. We're building a more resilient business by focusing on structural cost actions, commercial discipline, reliable supply and increased participation and high value end uses. Our upcoming merger with Huntsman will accelerate all of these. Now let's take a look at Winchester on slide seven. Out-the-door commercial ammunition demand continued to improve on a year-over-year basis during the third quarter. Year-to-date September NICS background checks for firearm purchases were up year-over-year for the first time since 2020. Our commercial order backlog continues to grow year-over-year as we remain very disciplined around value chain inventories, continuing our make-to-demand approach. As a result of the Winchester team's actions, The balance between channel inventories, consumer takeaway, and our own production is much healthier today than it was this time last year. Our military business continues to perform well. Winchester was awarded more than $1 billion in contracts during the quarter, approximately $600 million of which will be used to equip the new Lake City 6.8 millimeter ammunition facility. This month, Winchester delivered its first shipment of Lake City produced 6.8 millimeter rounds to the U.S. military. Our interim production capacity is expected to scale by a factor of 10 by the completion of the project as the new manufacturing facility is built out. These are the first rounds produced on U.S. government owned assets that meet the full requirements of the new 6.8 millimeter rounds, demonstrating the industry leading design engineering and manufacturing capabilities of our Winchester team. The Army also renewed our five-year second source supply contract with an initial delivery valued at $50 million over the next 12 months. This contract covers ammunition we produce for the military from our Oxford, Mississippi and East Alton, Illinois plants. These actions reinforce the US military's strong confidence in Winchester. I'll now turn the call over to Todd for a look at our financial highlights.

Thanks, Ken. Turning to slide eight, I'll review our working capital, liquidity, and financial position. Earlier this week, Olin executed a new credit agreement to support the combined company following our merger with Huntsman. Backed by strong commitments from our combined relationship bank group, the agreement will expand liquidity and financial flexibility for Olin Huntsman at closing. Working capital increased during the first nine months of 2026, reflecting our normal seasonal build and payments against previously accrued legacy litigation reserves. During 2026, Olin paid approximately $114 million to Shintech related to legacy litigation obligations. We do not expect further payments this year. We expect a seasonal reduction in working capital in the fourth quarter supported by continued inventory and receivables management, resulting in year-end working capital approximately in line with 2025 levels, excluding the impact of legacy litigation payments. We expect year-end net debt to be higher then year end 2025. Reflecting legacy litigation payments and merger related costs. We expect year end leverage to be approximately five times or slightly higher. The end of the quarter with $1.3 billion of available liquidity with no restrictions on the undrawn portion of our revolving credit facility. Our capital allocation priorities remain unchanged. We continue to target 2026 capital spending of approximately $200 million with investments focused on safe, reliable, and efficient operation of our assets. We expect to continue our long history of uninterrupted quarterly dividend payments with our next dividend marking 100 years of consecutive quarterly dividend payments. Finally, we remain committed to preserving liquidity and maintaining financial flexibility with excess cash flow to be used to reduce our outstanding debt. Deon 250 continues to generate strong momentum as we remain on track to deliver in the range of $110 to $120 million of incremental structural cost reductions in 2026. And annual savings expected to surpass our original $250 million target by 2028. This year, you have clearly seen the benefits from structural cost reductions in our epoxy business. However, in our chloralkali business, market and operating headwinds have offset the earnings benefit of these structural cost reductions. Our focus remains on cash generation, structural cost reductions, and disciplined capital allocation as we prepare for our merger with Huntsman. With that, Ken, I'll turn the call back to you.

Thanks, Todd. We'll finish with slide 9 and our outlook for the fourth quarter. We expect adjusted EBITDA to be in the range of $80 to $100 million for a full year 2026 adjusted EBITDA of approximately $550 to $570 million. In our CAPV business, we expect sequentially higher maintenance turnaround costs of approximately $25 million with sequentially lower domestic cost of soda pricing and seasonally lower demand for water treatment and construction. In addition, we expect to see year-end customer destocking at higher levels than normal. As we transition to 2027, we're seeing a firming caustic soda market with lower production aligned to seasonal chlorine demand and Asian exporters facing steep increases in freight costs as refined fuel products compete regionally for vessel availability. This has resulted in freight cost increases of more than $80 to $100 per ton for Asian caustic exports to Europe and Latin America, widening the U.S. Gulf Coast arbitrage and advantaging North American exporters. In epoxy, we face a $30 million sequential increase in turnaround costs. Many of these maintenance activities occur once every five years. In contrast, 2027 is expected to have very low epoxy plant turnaround costs and will continue to benefit from our structural cost reductions and commercial strategies that have been implemented during 2026. At Winchester, seasonally lower demand and sequentially higher copper costs will impact fourth quarter results, weighing upon otherwise constructive commercial demand. Commercial discipline will continue to be a high priority as we focus on improving margins and cash flow. We expect our defense business to be sequentially higher. To wrap up, We're highly focused on improving our results in the face of a challenging environment, but we're not standing still. We're operating with discipline, strengthening each of our businesses, and moving quickly to capture opportunities. With improved asset reliability, beyond 250 structural cost savings building, positive momentum at Winchester, and our Olin Huntsman integration to come, we're excited about the future. Our priorities are clear. Our team is energized and we're focused on execution and creating meaningful value for our shareholders. Consistent with these priorities is the 100th year of consecutive quarterly dividends expected to be paid in the fourth quarter. Thank you for your continued interest in OLIP. Operator, we're now ready to begin Q&A.

Thank you. We will now begin the question and answer session. To ask a question, you may press star, then 1 on your touchtone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star, then 2. At this time, we'll pause momentarily to assemble our roster. The first question will come from Frank Misch with Fermium Research. Please go ahead.

Hey, good morning. I wanted to drill into caustic soda. I think you indicated in the press release that you saw higher pricing. I believe that was domestic, but you saw lower export pricing. And then as your slide 15, you indicated that caustic pricing was actually down. Can you tell us what's been going on with caustic soda pricing within your system and what your expectations are?

Morning, Frank. For caustic soda, you know, it really is a global story. Domestically, we have seen prices improve slightly versus the second quarter. But you know, the challenges in the export market are related to not as much demand as it is related to the high volume of exports that we see coming out of China this year. You know, they've really, the full year, they've stepped up The amount of caustic exports coming out of China and that has continued. Now we're starting to see some challenges with that because of freight costs in Asia that are really related to what's going on in the Middle East. So that advantage for US Gulf Coast caustic is really coming back as freight costs remain high. and I think if you sort of track and watch what's going to happen in the freight markets, you'll probably be able to see what's happening around caustic because we're coming into a part of the season that is normally lower production. Demand is usually seasonally slower now as well. So we will see some tightening of markets because the liquidity in the market is not what it typically is based on the freight issues that we're seeing.

The next question will come from Josh Spector with UBS. Please go ahead.

Yeah, hi, good morning. I was wondering if you could talk about your latest thoughts around how you deal with the Shintac contract in 2030. Just assuming if you might need to build some PVC capacity, you might need to start that in the next year or so or at least get partners lined up. So any latest thoughts there would be appreciated. Thank you.

Good morning, Josh. Listen, our strategy around vinyls has not changed. We have said all along that we believe that the best path forward is for both Shentec and Olin to continue to work together. If that doesn't turn out to be the case, then we do have other options that we're looking at. That includes selling VCM to other parties. It includes potentially doing something in PVC. But we are not at a point now where we're ready to make any decision or any announcements. I'd say the chess pieces on the table are the same as they were even a year ago. I would expect that we will be making some sort of a more firm decision middle of next year to, you know, by the end of the third quarter. I think I'll be able to give you a better update on what we're going to be doing. But that fits. That timing fits. Very well with every option that we're looking at in terms of being able to execute it. And once we know more, I'll be sure and give you an update.

The next question will come from Hassan Ahmed with Alembic Global. Please go ahead.

Morning, Ken and Todd. You know, a question around synergies. I know you guys said that you would give more details later on, but and it just seems that the 400 million target that you guys gave, you know, I mean, you're talking about increased confidence around that. So I'm just trying to sort of figure out what's driving that. Have you seen more opportunities? Can we actually exceed that 400 million target as well?

Good morning, Hasan. Yeah, as you can imagine, you know, there's only so much that we can do prior to closing We're able to do a little bit more through clean teams in terms of looking at the cost structures and where we see opportunities for streamlining and making the organization more efficient after closing. But one thing we have not really looked at at all still is any opportunities around revenue synergy. So what I can tell you is that what we see is in terms of just the fixed costs and the overhead and the efficiency improvements that we see, I have a very high level of confidence in the $300 million. Remember, there was $100 million that's related to chlorine supply that kicks in in 2030. To me, that's going to be there. It's just a matter of time. The cost structure and what we see, which is really what the $300 million is, I have a very high level of confidence in that number. We will certainly, on the first earnings call after closing, be able to give you a little bit more details just in terms of how we see that phasing over time and how long it's going to take to be able to achieve that on a more, let's say, rateable or quarterly basis. We've given you some direction on an annual basis, but I think what I want to be able to do is explain a little bit more about how quickly in the short term we'll be able to deliver that. The teams are working extremely well together and just to give you one example, We've done some cultural surveys between Huntsman and Olin, and when you look at the results, what it shows is culturally we're very similar. That is encouraging to me that as we bring the companies together, we're going to be able to hit the ground running. Todd, I don't know if you want to add anything to that.

Todd Slater Ken, every time I talk about synergies, you keep wanting to raise the target on me, so I think you said it very well. you know, the teams candidly in the pre-closing integration phase are working well together and are, you know, really working on planning for day one and day one readiness and hit the ground running for synergy realization.

The next question will come from Alexey Yefremov with Barclays. Please go ahead.

Thanks. Good morning, everyone. Could you provide a year-over-year bridge for your ebidynes and chloro-vinyls? It looks like your profit index is up, your maintenance is a little bit up as well, but are there any other major factors that explain what's happening year-over-year?

Yeah. Hi, Alexi. Welcome back. Good to see you. are good to hear you, I should say. You know, if you look at chlorovinyl, one of the things that we had last year that's not recurring is a 45B benefit in the third quarter of 2025. We don't have that again this year. Sorry, go ahead, Don.

Yeah, no problem. I mean, Alexi, you know, the 45, the change in the hydrogen tax credit was roughly a little over $25 million year-over-year penalty. And you knew last year was a cumulative benefit. This year was about $5 million a quarter. We had talked earlier in the year in that $4 million to $5 million range a quarter. So that's what you see. The other thing is you do know we had the BCM issue where we had to reduce rates really during almost all of the third quarter this year. So that was roughly a $32 million headwind year-over-year. So, you know, more of a couple one-timers that masked some of the other things you talked about.

The next question will come from Jeff Tsakowskis with JP Morgan. Please go ahead.

Thanks very much. Do you expect your chlorovinyl utilization rates to change very much from the third quarter to the fourth quarter?

Good morning, Jeff. I would not expect the operating rates to change significantly. We've got some downtime coming up in the fourth quarter. We continue to operate below the industry, what you see reported for industry utilization rates. Part of that is related to the discipline that we're going to continue to show around operating our assets and maintaining values, but it's also related to some Planned outages and unplanned outages that are occurring either at the beginning of the quarter, and we've now worked out, or turnarounds that have slipped into Q4, but I don't see any significant change in the utilization rate for chlorovitals in the fourth quarter.

The next question will come from Salvatore Tiano with KeyBank Capital Markets. Please go ahead.

Yes, thank you very much. I want to ask a couple of things. Number one is, as we think about the VCM outage, if I understood correctly, you said that the plan was still out most of Q3 and was still over 30 million impact. So is it fair to assume that this becomes kind of a 30 million tailwind in Q4, perhaps adjusted for seasonality with additional upside in Q1? And secondly, You know, in your outlook, I think you're the only company so far talking about, you know, a more intense than usual desocking in Q4. Every other company has gone out of their way to say the expected calciumality. And I wonder, is this conservatism on your end? Or is it simply that you are actually seeing some of your chemical chains more severely soaking and you have line of sight to that?

Good morning, Sal. Listen, I'm going to start with the destocking question, then I'll let Todd take the first part of your question there on the VCM. You know, our view is what we have seen as we've gone through this trough, and you can really look at some of the data, Q4 seasonality is more accentuated than it has been in the past. So you can call it destocking and you can call it seasonality. Call it whatever you want. I think the reality is that the volatility in the fourth quarter is higher now than it has been in prior years. And we're not going to ignore that. I mean, I think it's prudent to make sure we reflect that in our outlook, and that's what we've done.

And Sal, as you think about the VCM, yeah, you talked about it coming up, you know, mid-September. So, yes, it was really out, you know, at reduced rates for virtually the whole quarter. So that $32 million, yeah, that's a tailwind in Q4. But as you see through our slides, chloralkali does have a roughly $25 million headwind going the other way on higher turnaround costs between Q3 and Q4. And just as a note, we would expect turnaround costs in the first quarter to be high as well in chloralkali.

The next question will come from Patrick Cunningham with the City. Please go ahead.

Hi, good morning. Just maybe a couple questions on Winchester. You know, it seems like you've seen some positive leading indicators. You talked about better channel health and commercial. As we look to the next 12 months, are there any other demand signals you're seeing? You know, do you expect to have a better platform for price and If you layer on the continued robust military growth, I guess what sort of earnings outlook do you have over the next 12 months or so?

Good morning, Patrick. Yeah, listen, the Winchester team has really done a great job dealing with some really strong headwinds here, mainly things related to costs for this year, mainly in metals, you know, propellants. not as much this year, but metals has been a real headwind. And it's not just copper, it's zinc, it's lead, it's pretty much every commodity that they buy. And they have been steadily pushing prices through. Really, we've just been keeping up with that metals inflation. And we're probably just looking at where copper is going in the fourth quarter. We're gonna be looking at doing something As we think about the new year, we've certainly got to respond to the copper prices that we've seen recently. We don't see anything in the short term that I think would give us pause in terms of thinking that it's going to be reversed. So we've got to stay on top of that, and the team is. You've seen the margins for Winchester. They have steadily improved, but they're still pretty significantly behind where they are historically. and so we've got to stay focused on doing everything we can to help ourselves and that includes operating our assets well. One of the things that Brett and his team are doing is getting really stuck into the Beyond 250 program and looking first at Lake City and understanding how we can become more efficient in operating that facility because every cost that we have we've got to put under scrutiny. The military demand is going to continue to be strong. And that's very good to see. But at the end of the day, you know, the commercial business is what really matters for us in terms of short-term earnings. And making sure that we can get the margins up there is my priority for right now.

The next question will come from Kevin McCarthy with Vertical Research. Please go ahead.

Thank you and good morning. Kenneth, welcome your comments on the subject of freight cost inflation and whether that is a net benefit or a headwind to Olin as a whole. It sounds like as it relates to cost, maybe it's helpful to the extent that it would insulate you from from competition, but I'm not sure about the impact on other parts of the company. So I would certainly welcome your broader view there.

Great question, Kevin. Thanks, and good morning. Listen, freight costs definitely helped us in the second quarter because that's what supported pricing. But I think we've now seen that. That is in the markets. and I'm really talking more specifically now about international trade related to things like Caustic and EVC. Those freight rates are also backing up and they will start impacting us as well. So, you know, it's just a matter of time before those costs start to creep into our freight lanes. If you think about other areas though where we're focusing on freight and other modes of transportation like epoxy, I mentioned this in the prepared remarks, With diesel costs up, if you're shipping anything by rail or by truck, your costs are up there as well. So net freight costs and costs of logistics is higher, and we've got to stay on top of being able to pass that through to the market, either through direct pricing or through some sort of surcharge. That's the word I was looking for. The next question will come from Abigail Ebers with Wells Fargo.

Please go ahead.

Thanks for taking my question. Another one on caustic soda, just your assumptions underpinning guidance. You're expecting higher caustic soda prices. It looks like DMA said cost settled up $5 in October and they're saying it could go up as much as another $10 in November. Is this realistic? Is this like around what you see underpinning guidance or would that imply some incremental upside?

Good morning, Abigail. Yeah, we see the same thing. We do see the market firming and we see spot pricing moving up and you will see some domestic pricing following that. With the lag that you see in the market, we'll start to see the More of that benefit in the first quarter than we're going to see here in the fourth quarter, but that's just how it's going to flow through the P&L. I think what you're reading would support, or we would support that in terms of what we've given as our outlook.

The next question will come from Matthew Deo with Bank of America. Please go ahead. Good morning.

So I wanted to talk a little bit about cash and cash flow because leverage is obviously ticking up here a bit into the close and I think there was the prior comments like 150 to 200 million in cash costs to achieve the synergies. So as you think about like case at which you can do this and I know Kenny kind of made a comment hopefully you can talk more about this but would you dip more and I Would you dip into the liquidity available to do this and take on a little bit more net debt to get at the synergies or is cash flow a governor on pace of synergy capture? And then related, unrelated, I know you'd made the comment that you paid $100 million to Shintech this year. Was that in 3Q or did that drop in October and would be a 4Q cash flow consideration?

Good morning, Matt. Listen, when you think about the synergies and the timing, what we had said when we first announced the merger is that the spend to get synergies is really going to be more, I shouldn't say back-end loaded, but later in the process of the first 24 to 36 months in terms of the spend for that to get synergies. The synergies that we can get early on are not going to require CapEx or significant amount of spend to be able to achieve that. So I would expect that early on the spend to achieve synergies is going to be modest, let's say that way. And then as we get into the process a little bit more as an integrated company, we'll start to see the other opportunities that might require some CapEx or some other expense to be able to realize. And if the business case justifies it and the return is there and the return is usually on synergies, the return is usually very fast. It's like months. And if we start to see business cases that have very high returns, then yes, we will go do that.

Regarding your question on cash flow and the legacy litigation payments of $114 million, 114 million dollars was spent through the end of the third quarter we had spent you know through the end of the first half you know just under a hundred and we had talked earlier on prior calls that you know 190 195 million dollars is going to be spent this year but what we've communicated on this call and to be clear we would only expect to spend a hundred and fourteen million dollars this year and that remaining liability we do not expect to be paid this year.

The next question will come from John Roberts with Mizuho. Please go ahead.

Thank you. How much do you think global caustic soda capacity increased in 2026 and how much do you think it might increase in 2027?

Good morning, John. Listen, we have talked about this before. If you look at the chloroply markets, they are set up structurally very well for the coming years. There's been a little bit of increase in capacity, but net of closures, it may be a few hundred thousand tons in 2026. That's nothing. I mean, it really is a rounding error in my mind, especially when you start factoring in unreliability of assets and that sort of thing. So structurally, I think that from a supply side, we are sitting in a very good place. And it's no different than what we have said even going back to our investor day. We're very optimistic about the outlook for the industry. What we need to see is some demand coming back. And that will be the biggest driver. As we start to see the global economy recover, and Europe seeing better growth options, China seeing better domestic growth and consumption. Those things are going to really start to show structurally that the market is in better shape than I think a lot of people believe.

The next question will come from Matthew Blair with TPH. Please go ahead.

Hey, good morning, and congrats on the billion in new ammo contracts. Do you have any details on the timing of when those contracts will roll through? And then also, is there any update on the application to take over? I believe it's the Radford ammo plant. Thank you.

Hey, good morning, Matthew. Thanks for joining us. Those contracts, the second source contract, you'll start to see that rolling through almost immediately. We already had that contract, so this is sort of a continuation of supply as the second source for the U.S. military. We're really happy to have that because, don't underestimate, I said this in the prepared remarks, Winchester is the industry leader in being able to develop products for the U.S. military. And the award of that contract just goes to show the confidence that they have in us, and we're really happy about that. In terms of the equipping phase for the 6.8 millimeter facility at Lake City, that's going to start to show up really more next year. We've got to place the orders for the equipment now that we've gotten the funding awarded from the government. And as that spend happens, you'll see that revenue come in But what you're going to see is there are other projects from this year that will start to come off. So you're not going to see that incrementally higher. It's probably going to be more stable in terms of project revenue next year as the project this year that was spending to build the plant, to actually build the building, that's completed. Now we're going to be doing the equipping phase, and that's going to kick in next year. So hopefully that helps. Oh, sorry. So Chris, I do want to answer one more thing on Radford. Sorry, I forgot that Matthew asked about Radford. That process has slowed, and that's been a decision by the government to slow that down. I think I had mentioned previously that just looking at that from what was bid or put in the RFP by the government, frankly, just did not look compelling for us. and that really is to me right now is going to be on hold. I don't see anything happening on that in the near term. So I just want to make sure I answered that part as well.

The next question will come from Arun Viswanathan with RBC. Please go ahead.

Great. Thanks for taking my question. I hope you guys are well. I guess I just wanted to ask about some of your markets and If you've experienced increased production out of China in the June through September period and did it really pick up in say maybe some of the coal-based chlorine applications and is that making you know and caustic soda and is that resulting in Thank you. Good morning, Arun.

What we saw back when the conflict in the Middle East broke out and prices for PVC spiked is you saw everybody that could make PVC was ramping up, and that included the carbide-based PVC in China. And then what has happened since, you know, when that slug of material was produced, there was a lot of caustic that was produced along with it. That has been working its way through the market. We talked about that on the second quarter earnings call. And as, you know, oil prices stay high, the ethylene-based PVC is was out of the money. So you couldn't make money on a cash basis on PVC with oil prices. Brent's sitting at 105 to 115. It's just not in the cards. Coal-based, you could. What we have seen over the past couple of months, though, is with the higher energy prices now beginning to filter through even in China, even the coal-based, carbide-based, Thank you for joining us. I think there's going to continue to be a lot of volatility and elevated prices for oil and that's going to filter through to the energy base and I think even this morning there was an announcement about a European producer closing production of core alkali so it is starting to trickle through into the market and that's going to help support what we have put out as our guidance which is things will get tighter as we go into the new year.

The next question will come from Peter Osterlund with Truist. Please go ahead.

Hi, this is Alec on for Pete. I wanted to ask about sort of what's left as far as cost reductions next year. As we get into Beyond 250 and that $60 to $80 million target, how do you see that as far as being allocated between the segments.

Good morning, Alex. We have done a really good job on Beyond 250. Todd talked about this in his prepared remarks. You can see that coming through in the epoxy business. Next year, we're going to have another increment, and this is in the appendix slides. $60 to $80 million is what we would expect for next year. This year, we're going to be $110 to $120 million. If I look at that year over year, even though in the prepared remarks we had said, you know, you really can't see that yet in the bottom line in CAPV, if you look at our manufacturing costs in CAPV, they are down year over year, mid-single digits. But you can't see that because of a lot of the other noise that's coming through. That gives me a whole lot of confidence that structurally those costs are out. and our teams in manufacturing have done a great job adjusting to new processes, new work processes. We've improved things like our time on tools and our overtime. Those things we are tracking very closely and the manufacturing facilities are doing a great job at improving those.

If you think about Beyond 250, you know, and Ken mentioned and I mentioned earlier about epoxy, that structural cost reduction really underpins one of the key pillars of the epoxy change year over year. And that structural cost, you know, and we had talked about this early on, 40 to 50 million dollar improvement, you know, in that year over year and beyond 250 in epoxy. Boracly clearly is the remaining big piece for this year in that structural cost improvement. and you heard Ken's comments about our underlying manufacturing costs really being lower. Again, we talked about the VCM issue this year. Between the second and third quarter of the operating at lower rates for that time period, that's a little over $70 million of headwind that we've incurred this year. but those structural costs are out. And so that's a temporary headwind that occurred in 2026. But those structural costs are permanently gone.

The next question will come from David Begleiter with Deutsche Bank. Please go ahead.

David Begleiter Good morning. Ken, looking at some consultant China caustic export data, They're showing a modest increase in exports, only the last one this year, from about 4.1 to 4.2 million tons, but then a sharp decline next year by about 25%. So is that data just either lagging or missing some ingredients? And would you concur that we should see a sharp reduction in China costing exports next year? Thank you.

Good morning, Dave. I think you've got to go back a couple of years, too, to look at that caustic export, because if you go back to 2024, it's stepped up a lot. And so it has stayed elevated in 2025. And then we saw another increment in 2026. And that has been disruptive in the market. You know, and I will just say, call a spade a spade, you know, they're paying people to take, you know, they're selling chlorine at negative values to subsidize that. That's what's going on here. and I hope that we see a 25% reduction in caustic exports next year. So I hope that that report is right, but I will be a skeptic because I think that that has not been the typical behavior that we have seen. So what we are focused on right now is what we can control and that is operating our assets reliably and being able to participate in the markets in the most valuable way that we can. We are doing a great job with that. We've had stable ECU values domestically. We are strengthening our positions in the export markets where we're choosing to play, and that will continue into 2027. So I hope that that report that you're reading is correct, because that would be very good for us.

As there are no further questions, this concludes our question and answer session. I would like to turn the conference back over to Ken Lane for closing comments.

Thank you, Nick, and thank you everyone for joining us. We do look forward to sharing more with you about Olin Huntsman in the coming weeks and months. It's an exciting time for Olin, and we very much appreciate your interest in our company. Thank you and have a great weekend.

Thank you for attending today's presentation. You may now disconnect.